Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients.
Ann Med
; 55(1): 379-387, 2023 12.
Article
en En
| MEDLINE
| ID: mdl-36607317
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Deterioro Clínico
/
COVID-19
Tipo de estudio:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Límite:
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article